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PreviewsSweetening Cyclic Peptide
Libraries
Enzymatic macrolactamization of linear glycosidated
peptides provides access to an important class of
drug-like molecules. The work presented in this issue
[1] shows that it may be possible to make complex
libraries of glycosidated cyclic peptides by incorpo-
rating glycosidated amino acids into linear peptides
via solid-phase peptide synthesis followed by thioes-
terase-mediated peptide cyclization.
From a drug discovery standpoint, cyclic peptides pos-
sess many advantageous properties. Large peptide li-
braries can be readily assembled from the vast array of
available amino acids. The cyclic nature of the com-
pounds allows the molecules to populate a defined mo-
lecular structure. These two factors permit sampling of
a large amount of conformational space, increasing the
likelihood of identifying or optimizing biological activ-
ity. Cyclic peptides are also predisposed to favorable
pharmacokinetic properties, including metabolism and
excretion. Additionally, they are more resistant to pro-
teases than their linear analogs, increasing their serum
stability. The combination of these factors makes cyclic
peptides a useful core structure for drug development
via combinatorial library screening [2].
However, cyclic peptides have serious limitations as
a platform for drug discovery. Critically, they are poor
at crossing biologically relevant membranes, severely
limiting their utility as pharmaceutical agents. Addition-
ally, chemical cyclization of linear peptides is challeng-
ing and sequence dependent, limiting library size and
biasing libraries toward particular regions of conforma-
tional space.
Glycosidation substantially improves the pharmaco-
logical characteristics of cyclic peptides. Cellular up-
take and solubility can be enhanced by glycosidation.
Glycosidation provides a potential mechanism to target
cyclic peptides to specific cell types. The promise of
glycosidated cyclic peptide libraries, with their intrinsi-
cally favorable pharmacokinetics and high levels of mo-
lecular diversity, is tempered only by the difficulty of
constructing these compounds.
Construction of cyclic peptide libraries is a challeng-
ing task due to the inherent difficulty in cyclizing linear
peptides. The trans configuration of the amide bonds
in linear peptides prevents the reactive C and N termini
from reaching each other. A number of chemical meth-
ods are available for the formation of cyclic peptides
[3]. These approaches require linear peptide conforma-
tions that place the C and N termini in close proximity.
This proximity is enforced via specific amino acid se-
quences (e.g., gly- or pro-rich sequences, mixtures of
D and L amino acids), limiting the applicability of these
methodologies to large library construction.
Enzymatic approaches have proved effective at gen-
erating diverse libraries of cyclic peptides. Split intein-based approaches are capable of generating cyclic
peptide libraries without the structural biases required
in chemical approaches [4]. This methodology however
has two serious limitations. Since the inteins are ex-
pressed in vivo, purification of the cyclic peptide pro-
ducts is challenging and the peptide diversity is limited
to proteinogenic amino acids.
Walsh and coworkers have successfully used recom-
binant thioesterase (TE) from the tyrocidine biosyn-
thetic pathway to construct a library of cyclic peptides
[5]. The cyclic decapeptide tyrocidine is generated bio-
synthetically by a nonribosomal peptide synthetase
(NRPS) system [6]. These multienzyme systems, which
also generate molecules like gramicidin and vancomy-
cin, catalyze the formation of a linear peptide that is
linked as a covalent acyl-enzyme intermediate to the
enzyme. The final enzyme in the pathways is the TE,
which catalyzes cyclization and release of the product.
Purified recombinant tyrocidine TE can convert linear
peptides into cyclic peptide products efficiently in vitro.
Studies have shown that the TE is remarkably tolerant
to changes in the linear peptide [7]. Linear peptides of
various lengths are cyclized (6–14 amino acids) and re-
placement of most amino acids is tolerated by the TE.
The crucial structural elements that permit enzymatic
recognition and cyclization of the substrate appear to
be the N-terminal amino acid residue and the penulti-
mate C-terminal amino acid. Changing either of these
amino acids dramatically attenuates enzymatic cycliza-
tion. The otherwise broad substrate tolerance makes it
possible to use the TE-mediated cyclization in library
formation since one can be confident that cyclic pep-
tide products are generated for the large majority of
library members [5]. This is important in large library
synthesis since each library member cannot be as-
sayed for chemical structure or purity. An additional ad-
vantage is that the linear peptide substrates are syn-
thesized by solid-phase peptide synthesis (SPPS),
allowing for the incorporation of nonproteinogenic
amino acids and increasing the potential library scope.
Glycosidation of cyclic peptides is not currently use-
ful for accessing large libraries of glycosidated cyclic
peptides. While chemical glycosidation of cyclic pep-
tides is an appealing approach to carbohydrate intro-
duction, this method suffers from multiple drawbacks
in a library context [8]. In particular, the peptide sub-
strates are highly insoluble in the anhydrous organic
solvents required for sucessful glycosidation [9]. Addi-
tionally, there is little regiochemical control of glycosy-
lation, which leads to heterogeneity of each library
member, complicating library screening and evaulation.
Enzymatic glycosidation of cyclic peptides is also not
suited for large library synthesis. The limiting factor in
enzymatic glycosidation is the substrate specificity of
the glycotransferases. Glycotransferases are highly
specific to both their sugar and aglycon substrates. For
effective synthesis of a diverse library, this specificity
needs to be dramatically attenuated. Unfortunately, no
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multipurpose glycotransferase has been characterized c
to date [10]. z
Recognizing the difficulties associated with glycosi- s
dation of cyclic peptides, Lin et al. [1] opted to explore s
the TE-mediated cyclization of glycosidated linear pep- w
tides. One advantage of this approach is the well-docu- d
mented literature detailing the regioselective incorpora- c
tion of sugars into linear peptides via SPPS [8]. Since
the tyrocidine TE domain was known to be tolerant to C
substantial modification of the linear peptide, it was an- D
ticipated that glycosidation would not adversely effect S
the cyclization activity. S
A variety of linear O-linked glycosidated peptides
were prepared by FMOC SPPS, using glycosidated ser-
ine or tyrosine residues. The TE domain catalyzed cycli- S
zation of all the glycosidated peptides tested (Figure 1).
The TE was tolerant of glycosidation at amino acids 5–7.
Cyclization kinetics were essentially unaffected by the
composition of the carbohydrate (Glc, GlcNAc, GlcNH2,
Gal). Fully protected carbohydrates (tetraacetates) were
also processed by the TE domain. Reduced cyclization
efficiency was observed when amino acid 8 was gly-
cosidated; however, these reactions still generated the
desired product.
These results suggest that TE-mediated cyclization
of glycosidated linear peptides may be an effective
route for generating libraries. Introduction of the sugar
residue by SPPS allows carbohydrate complexity to be
generated into linear peptides. Independence of cycli- 1
zation kinetics from carbohydrate identity and regio-c
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sFigure 1. Linear Glycosidated Peptides Were Synthesized by FMOC
kSPPS and Successfully Cyclized by Purified Recombinant Tyroci-
dine TE T
themistry suggest that this method may faithfully in-
orporate the diversity of a linear peptide library into
yclized compounds.
This work raises a number of interesting questions
hat will need to be addressed before the scope of the
ethodology can be determined. Cyclization of the
rotected carbohydrates suggests that the TE domain
ight also cyclize oligosaccharide decorated com-
ounds. Will the TE domain also tolerate multiple sugar
ttachment sites? Will the TE domain tolerate glycosi-
ation at the other amino acid residues? Will it be pos-
ible to introduce depsipeptide linkages or peptidomi-
etic scaffolds into these systems? These questions
ill help define the limits of carbohydrate and peptide
omplexity that can be introduced via the tyrocidine
ystem. There are also a host of other TE domains
nown and many more still to be identified. Will these
E also exhibit relaxed substrate specificity and will
hey tolerate gycosidation of their linear substrate? If
o, these enzymatic domains may provide a way to ac-
ess glycosidated cyclic peptides with different en-
yme recognition elements, dramatically different ring
izes, or with different types of cyclization (i.e., through
ide chain rather than backbone functionality). This
ork opens the door to an exciting and promising new
irection for the synthesis of complex libraries of gly-
osidated cyclic peptides.
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